Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.
A major Wall Street firm that specializes in Bio and Medtech Companies has a $12 price target out on Athersys from one...
Todos Medical (TOMDF) Issues Another CoronaVirus Headline, Gains 60%.
Companies With 'CoronaVirus' in Their Press Release Today:
Waitr (WTRH) up 86% - Online Food Ordering for Quarantined...
Aphex BioCleanse Systems Appoints Respected Marketing Veteran Mark Washo as Senior Vice President of...
PITTSFORD, N.Y., Nov. 12, 2020
PITTSFORD, N.Y. , Nov. 12, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization...
Innovus (INNV) Hits the Trifecta. Stuffy Noses, Hair Loss & Heartburn.
Innovative Innovus now has Three Shots on Goal with non-prescription drugs which have come off patent including a new competitor to...
Hapbee Closes $6.5 Million Private Placement and Provides Corporate Update.
VANCOUVER, BC, July 17, 2020 /PRNewswire/ - Hapbee Technologies, Inc. ("Hapbee" or the "Company"), a wellness technology company developing the revolutionary Hapbee wearable, is pleased to announce...
2021 Breakthrough Wearable Tech: Overview on Hapbee (HAPB, HAPBF) and its Vision
LIVE CHART
https://youtu.be/X_DRzL6MAOU
Biotech Stock Review Adds NanoVibronix (NAOV) $2.95, to Watch List.
NanoVibronix Announces Closing of $3.2 Million Private Placement to Existing Shareholders.
Adding to Watch List @ $2.95*...
Short Squeeze Mania.
Citius Pharma (CTXR) Locked and Loaded.
Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen...
Greenbrook Health Centers (GBNH) Changing the Way Depression is Treated.
Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence
https://youtu.be/yrr-wlFftT0
Adding Aphex BioCleanse Systems (SNST) to CoronaVirus Watch List.
Former Eastman Kodak Scientist Engineers Develop Liquid Germ Killer Hy-IQ™ Water to Revolutionize how Deadly Bacteria and Virus are Eradicated
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
